Answers are grounded in this paper and cite their sources.
Sulforaphane (SFN) is a naturally occurring bioactive compound widely present in cruciferous vegetables, and its anti-tumor, anti-inflammatory, and other activities have been extensively studied. This study adopts a network pharmacology approach, aiming to analyze and elucidate the core targets and pathways of SFN across these four pharmacological effects. In this study, relevant targets were first obtained using SwissTargetPrediction and PharmMapper. Subsequently, GO analysis and KEGG enrichment analysis were performed to uncover its action sites in the human body, the functions of the associated target genes, the biological processes involved, and the resulting effects. Further interpretation of the PPI network provides additional insight into its pharmacological actions from the levels of targets and pathways. Based on this, the present paper offers a systematic summary of SFN’s anti-tumor, anti-inflammatory, adjunctive therapy for diabetes, and neuroprotective effects by integrating targets and pathways, and compares these findings with previous studies. In conclusion, sulforaphane, as a promising natural compound with therapeutic and intervention potential in multiple areas, holds promise for contributing to the treatment of related diseases in the future and bringing new hope and prospects to patients undergoing treatment or individuals aiming to prevent these conditions.
No takes yet. Share an insight, caveat, or question.
Jiaxin Liu (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: